Back to Search
Start Over
Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1/IKAROS mutations
Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1/IKAROS mutations
- Source :
- Journal of Allergy and Clinical Immunology, Journal of Allergy and Clinical Immunology, Elsevier, 2019, 144 (1), pp.339-342. ⟨10.1016/j.jaci.2019.03.025⟩, Journal of Allergy and Clinical Immunology, 2019, 144 (1), pp.339-342. ⟨10.1016/j.jaci.2019.03.025⟩
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- International audience
- Subjects :
- [SDV]Life Sciences [q-bio]
Immunology
Dominant negative
Graft vs Host Disease
Ikaros Transcription Factor
03 medical and health sciences
0302 clinical medicine
Text mining
Humans
Immunology and Allergy
Medicine
Child
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
0303 health sciences
business.industry
Hematopoietic Stem Cell Transplantation
Infant
3. Good health
Treatment Outcome
Child, Preschool
030220 oncology & carcinogenesis
Mutation
Cancer research
[SDV.IMM]Life Sciences [q-bio]/Immunology
Allogeneic hematopoietic stem cell transplant
business
Subjects
Details
- ISSN :
- 00916749
- Volume :
- 144
- Database :
- OpenAIRE
- Journal :
- Journal of Allergy and Clinical Immunology
- Accession number :
- edsair.doi.dedup.....d74071a96808fb079e51a92a0c162046
- Full Text :
- https://doi.org/10.1016/j.jaci.2019.03.025